SNAP | Stock Discussion Forums

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical
SNAP

An SI Board Since February 1997

Posts	SubjectMarks	Bans	Symbol
124	13	0	SNAP

Emcee: scaram(o)uche	Type: Unmoderated

Min Hr Day Wk Mon Yr 3 Yr Log

Introduction Market Data Compact

SNAP 7.795

+2.8%

3:59 PM EDT

Top Headlines - Snap Inc.

'Performative rage': Analyst scoffs at Senate GOP leader's shocking outburst at Dems 45 minutes ago

Trump needs ‘guidance’ before deciding whether to comply with judges’ SNAP order 46 minutes ago

'Utter lie!' Elon Musk's wild immigration claim flattened by legal expert 60 minutes ago

Gov. Beshear declares state of emergency ahead of SNAP benefit halt, funding $5 million to local foo an hour ago

SNAP showdown: US judges order USDA to use emergency funds for food stamps; Trump seeks court clarif an hour ago

Go to reply# or date (mm/dd/yy):

Reply	Message Preview	From	Recs	Posted
124	Kathleen Mullinix is CEO of WellGen (as of September 2006) wellgen.com	Mike McFarland	-	3/24/2007
123	CNS Drugs. 2006;20(8):633-54. Links Galanin receptor antagonists : a potential	scaram(o)uche	-	8/11/2006
122	Errol de Souza, Ph.D., has been appointed President and CEO synapticcorp.com	Mike McFarland	-	9/10/2002
121	Synaptic Pharmaceutical Enters Into an Agreement with Ranbaxy for a License to I	nigel bates	-	7/11/2002
120	Synaptic Pharmaceutical Licenses Compounds To Procter & Gamble PARAMUS, N.J	nigel bates	-	7/10/2002
119	Synaptic Pharmaceutical Initiates Phase-I Clinical Trial For Antidepressant SNEC	nigel bates	-	2/5/2002
118	PARAMUS, N.J.--(BUSINESS WIRE)--Feb. 4, 2002--Synaptic Pharmaceutical Corporatio	nigel bates	-	2/4/2002
117	Never noticed this (& had almost forgotten I owned a few <g>) - PARAM	nigel bates	-	1/10/2002
116	CAT, INCY, SNAP: it's clearly change of management week - Synaptic Pharmace	nigel bates	-	11/27/2001
115	PHILADELPHIA, Nov. 16 /PRNewswire/ -- The leading industry and academic research	nigel bates	-	11/16/2001
114	Featured in The Scientist's 'hot paper' of the month - (http://www.	nigel bates	-	11/6/2001
113	Synaptic Pharmaceutical Closes $41.0 Million Private Financing Led By Warburg Pi	nigel bates	-	9/27/2001
112	PARAMUS, N.J., Aug. 6 /PRNewswire/ -- Synaptic Pharmaceutical Corporation (Nasda	nigel bates	-	8/6/2001
111	Would it not be sensible for them to sell themselves to someone like NBIX ? My g	nigel bates	-	7/19/2001
110	The Looney Brothers, together with some consulting group that had it's head	scaram(o)uche	-	7/18/2001
109	Synaptic Pharmaceutical Scientists Use 'Biogenomics' to Find Elusive Rec	nigel bates	-	7/18/2001
108	Whatever the reason, looks like the shares will be fixed, er, affixed to a new	Mike McFarland	-	7/17/2001
107	Mike, In 5 days of "decline" the total trading volume was 29500 shares	hmpa	-	7/13/2001
106	Just chit chat here Miljenko, no bioscience, so disregard if shareprice banter a	Mike McFarland	-	7/13/2001
105	I am sure that almost all pharma are looking for antagonist of the new MCH2 rece	Miljenko Zuanic	-	6/21/2001
104	Just to add a couple of notes to the MCH receptor arena. SNAP was issued two US	Biotech Jim	-	6/21/2001
103	Proc. Natl. Acad. Sci. USA, Vol. 98, Issue 13, 7564-7569, June 19, 2001 Neurobio	Miljenko Zuanic	-	6/19/2001
102	12/11/2000 Synaptic Pharmaceutical Awarded Patent For The Alpha Adrenergic 1B an	Mike McFarland	-	2/2/2001
101	Shareholder grumble-- (from Yahoo) 12-Oct-00 MULLINIX, KATHLEEN P Chairman of t	Mike McFarland	-	11/18/2000
100	Synaptic Pharmaceutical Announces Discovery of New Class of Receptors synapticco	Mike McFarland	-	11/8/2000

Go to reply# or date (mm/dd/yy):